APT Medical's (SHA:688617) net profit attributable to shareholders in 2024 rose 26% to 673.2 million yuan from 533.9 million yuan a year earlier, according to a Wednesday filing with the Shanghai Stock Exchange.
Earnings per share climbed 27% year on year to 6.92 yuan from 5.46 yuan.
The Chinese medical device company's operating income in the same period inched 25% higher to 2.07 billion yuan from 1.65 billion yuan in the previous year, the filing said.
The company's shares dropped 4% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.